Neuroprotective Effect of Extract-fractions from Sceletium tortuosum and their Preliminary Constituents Identification by UPLC-qTOF-MS with Collision Energy and MassFragment Software
Authors/Creators
- 1. College of Pharmacy, Jinan University, Guangzhou, China
- 2. Faculty of Pharmacy, Rhodes University, Grahamstown, South Africa
- 3. Faculty of Pharmacy, Rhodes University, Grahamstown, South Africa; Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada
- 4. , Jinan University, Guangzhou, China
Description
Abstract:
Aim The objective of this study was to investigate solvent extracts of Sceletium tortuosum for their neuroprotective effect and further identify the constituents in the pharmacologically active solvent fractions.
Methods Sceletium tortuosum material was extracted with petroleum ether and ethyl acetate respectively. The extracts were further subjected to silica-gel column chromatography to obtain six sub-fractions. The sub-factions were tested for neuroprotective effects based on their evaluation in MPP+-injured N2a cells and L-glutamate-injured PC12 cells by MTT assay. The sub-fractions were further tested by ultraperformance liquid chromatography (UPLC) coupled to quadrupole-time-of-flight mass spectrometry (qTOF) with collision energy (MSE) to identify relevant constituents using MassFragment software in Masslynx4 software.
Results The highly non-polar petroleum ether fraction and the polar ethyl acetate fraction showed potential in vitro neuroprotective activity. The UPLC-qTOF-MSE results of sub-fractions indicated the presence of dihydrojoubertiamine, mesembrenone, mesembrine, 2-oxomesembrine, Δ7-mesembrenone, N-demethyl-N-formylmesembrenone, dihydrobuphanamine acetate, sceletium A4, sceletenone, Δ7-N-demethyl-mesembrenone, 2-oxomesembranol, N-methyldihydrojoubertinamine and other unnamed components.
Conclusion The polar and nonpolar extracts of Sceletium tortuosum exhibit neuroprotective effect in N2a cells or PC12 cells injured by MPP+ or L-glutamate respectively. Two sub-fractions each of the petroleum ether and ethyl acetate fractions were observed to have comparatively higher neuroprotective efficacy than other sub-fractions and the MS profile indicated the presence of dihydrojoubertiamine and an unidentified non-alkaloid in these two sub-fractions. While the presence of mesembrine, mesembrenone and other alkaloids were observed in the other two neuroprotective sub-fractions, the results indicate that there are unidentified constituents of Sceletium tortuosum that require further investigation.
Notes
Files
JPBMS_Pei Yu_02_031_46.pdf
Additional details
References
- 1. Filipović SR, Covicković-Sternić N, Stojanović-Svetel M, Lecić D, Kostić VS. Depression in Parkinson's disease: an EEG frequency analysis study. Parkinsonism Relat Disord. 1998 Dec;4(4):171-8. doi: 10.1016/s1353-8020(98)00027-3. [PubMed]
- 2. Gericke N, Harvey A, Viljoen A, Hofmeyr D, inventors; H.L. Hall & Sons Limited, S. Afr. . assignee. Sceletium extract and uses thereof patent US20120004275A1. 2012. 3. Dimpfel W, inventor; HG&H Pharmaceuticals Pty. Ltd., S. Afr. . assignee. Mesembrenol and/or mesembranol for prophylaxis and treatment of patients suffering from epilepsy and associated diseases patent WO2019021196A1. 2019.
- 3. Dimpfel W, inventor; HG&H Pharmaceuticals Pty. Ltd., S. Afr. . assignee. Mesembrenol and/or mesembranol for prophylaxis and treatment of patients suffering from epilepsy and associated diseases patent WO2019021196A1. 2019.
- 4. Loria MJ, Ali Z, Abe N, Sufka KJ, Khan IA. Effects of Sceletium tortuosum in rats. J Ethnopharmacol. 2014 Aug 8;155(1):731-5. doi: 10.1016/j.jep.2014.06.007
- 5. Chiu S, Gericke N, Farina-Woodbury M, Badmaev V, Raheb H, Terpstra K, Antongiorgi J, Bureau Y, Cernovsky Z, Hou J, Sanchez V, Williams M, Copen J, Husni M, Goble L. Proof-of-Concept Randomized Controlled Study of Cognition Effects of the Proprietary Extract Sceletium tortuosum (Zembrin) Targeting Phosphodiesterase-4 in Cognitively Healthy Subjects: Implications for Alzheimer's Dementia. Evid Based Complement Alternat Med. 2014;2014:682014. doi: 10.1155/2014/682014. [PubMed]
- 6. Hoffman JR, Markus I, Dubnov-Raz G, Gepner Y. Ergogenic Effects of 8 Days of Sceletium Tortuosum Supplementation on Mood, Visual Tracking, and Reaction in Recreationally Trained Men and Women. J Strength Cond Res. 2020 Sep;34(9):2476-2481. doi: 10.1519/JSC.0000000000003693.[PubMed]
- 7. Singh SK, Srivastav S, Castellani RJ, Plascencia-Villa G, Perry G. Neuroprotective and Antioxidant Effect of Ginkgo biloba Extract Against AD and Other Neurological Disorders. Neurotherapeutics. 2019 Jul;16(3):666-674. doi: 10.1007/s13311-019-00767-8. [PubMed]
- 8. Davies J, Chen J, Pink R, Carter D, Saunders N, Sotiriadis G, Bai B, Pan Y, Howlett D, Payne A, Randeva H, Karteris E. Orexin receptors exert a neuroprotective effect in Alzheimer's disease (AD) via heterodimerization with GPR103. Sci Rep. 2015 Jul 30;5:12584. doi: 10.1038/srep12584. [PubMed]
- 9. González-Burgos E, Liaudanskas M, Viškelis J, Žvikas V, Janulis V, Gómez-Serranillos MP. Antioxidant activity, neuroprotective properties and bioactive constituents analysis of varying polarity extracts from Eucalyptus globulus leaves. J Food Drug Anal. 2018 Oct;26(4):1293-1302. doi: 10.1016/j.jfda.2018.05.010. [PubMed]
- 10. Ren Z, Zhang R, Li Y, Li Y, Yang Z, Yang H. Ferulic acid exerts neuroprotective effects against cerebral ischemia/reperfusion-induced injury via antioxidant and anti-apoptotic mechanisms in vitro and in vivo. Int J Mol Med. 2017 Nov;40(5):1444-1456. doi: 10.3892/ijmm.2017.3127. [PubMed]